PDS Biotechnology
PDSB
PDSB
64 hedge funds and large institutions have $89.3M invested in PDS Biotechnology in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 19 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
+17
Holders Change %
+36.17%
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
25
Increased
19
Reduced
10
Closed
7
Calls
$12.1M
Puts
$2.51M
Net Calls
+$9.54M
Net Calls Change
+$7.73M
Top Buyers
| 1 |
Millennium Management
New York
|
$5.96M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
$4.36M |
| 3 |
D.E. Shaw & Co
New York
|
$4.48M |
| 4 |
Morgan Stanley
New York
|
$2.95M |
| 5 |
Two Sigma Investments
New York
|
$6.55M |
Top Sellers
| 1 |
LPL Financial
San Diego,
California
|
$5M |
| 2 |
Citadel Advisors
Miami,
Florida
|
$359K |
| 3 |
Renaissance Technologies
New York
|
$3.27M |
| 4 |
NLVP
New Leaf Venture Partners
New York
|
$0 |
| 5 |
BlackRock
New York
|
$5.97M |
